Electronic Health Records

Use & Optimization News

International Health IT Project Will Utilize Allscripts EHR

Chicago-based Northwestern Medicine has teamed up with Alfardan Group in Qatar to extend Allscripts EHR to the Middle East.

Allscripts will strengthen its presence in the Middle Eastern market with a new international health IT project.

Source: Thinkstock

By Kate Monica

- A joint international health IT project between Chicago-based Northwestern Medicine and Alfardan Group in Qatar will enable providers and patients in the Middle East to utilize Allscripts EHR for well-informed care delivery.

Northwestern Medicine has teamed up with Alfardan Group — a family-owned conglomerate based in Qatar — to provide ambulatory care services for patients in the Middle East.

The project is part of Allscripts expansion into international markets. Alfardan Medical with Northwestern Medicine will enable Qatar residents to use Allscripts health IT solutions including Sunrise Ambulatory Care, Sunrise Surgical Care, Sunrise Radiology, Allscripts Clinical Performance Management, Allscripts Lab, and iPro Anesthesia.

The project is the first of Alfardan Group’s investments in the health IT sector. The conglomerate’s partnership with Northwestern Medicine is Alfardan Group’s first step toward achieving its vision of developing projects that will improve social conditions and quality of life for Qatar residents.

Alfardan Medical with Northwestern Medicine will ensure Qatar patients have the opportunity to access high quality healthcare in a range of multidisciplinary medical specializations.

“Alfardan Group has built its reputation on offering our clients a lifestyle in keeping with the quality and premium services that they value,” said Omar Hussain, Alfardan Group President and Chief Executive Officer. “We believe Allscripts is the suitable partner to help us deliver world-class integrated healthcare to Qatar.”

Ambulatory healthcare organizations in Qatar will use Allscripts surgical, radiology, and laboratory health IT solutions to enable efficient and safe care through a user-friendly EHR interface. The solution will function as an evidence-based, single platform with integrated data analytics to deliver personalized medicine.

Allscripts Sunrise solution will offer providers access to a single patient health record that includes patient-centered functionality to ensure patients have access to their own health information.

“We are pleased to have the opportunity to partner with Alfardan Group and Northwestern Medicine in its new project,” said Alan Fowles, Allscripts Global President. “With the help of this new partnership in the Middle East, we can demonstrate the value of Allscripts commitment to open, connected communities of care to its people and across the globe.”

Allscripts also recently launched new functionality for users enabling EHR-integrated multifactor authentication to improve identity proofing when electronically prescribing controlled substances.

The health IT company partnered with identity proofing services provider ID.me to enable providers to verify their identity online in compliance with Drug Enforcement Administration (DEA) regulations.

Users will have access to the new feature starting in march 2019. Healthcare providers will be required by federal law to completely stop using paper processes to prescribe controlled substances and transition to only using electronic prescribing for controlled substances (EPCS) EHR functionality after January 2021. 

The new feature will allow Allscripts prescribers to verify their identity and validate their credentials, including their DEA and NPI identifiers. Registration for multifactor authentication is conducted through an online self-serve flow or over video chat with an ID.me call center representative.

ID.me is working to simplify the identity proofing process and enable individuals to securely share their identity online. The IT company is currently developing a digital identity network where users will only need to verify their identity once across any organizations where ID.me is accepted.

“With secure digital identity, malicious actors will have a much more difficult time perpetrating opioid abuse,” said ID.me CEO and founder Blake Hall.

“Our solution conforms to rigorous federal requirements for prescribing controlled substances, yet we have taken great care to ensure the process is also accessible for providers so they can spend as much time as possible caring for patients,” Hall continued.

X

EHRIntelligence

Sign up to continue reading and gain Free Access to all our resources.

Sign up for our free newsletter and join 60,000 of your peers to stay up to date with tips and advice on:

EHR Optimization
EHR Interoperability
MACRA

White Papers, Webcasts, Featured Articles and Exclusive Interviews

Our privacy policy


no, thanks

Continue to site...